New Analysis Reveals First-Line Treatment Data on SIR-Spheres® Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer
BARCELONA, Spain, July 3, 2017 /PRNewswire/ -- SIRFLOX and FOXFIRE Global findings suggest that adding liver-directed Selective Internal Radiation Therapy (SIRT) to standard first-line chemotherapy may improve overall survival in metastatic colorectal cancer (mCRC) patients with right-sided pri...
SIR-Spheres(R) Y-90 Resin Microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study Against Standard Treatment Shows
AMSTERDAM, April 24, 2017 /PRNewswire/ -- 459-patient SARAH Study shows that local treatments of advanced or inoperable Hepatocellular Cancer (HCC) with SIR-SpheresY-90 resin microspheres did not lead to a planned superiority difference in overall survival compared to daily standard-of-care sys...
New European Society of Medical Oncology (ESMO) Biliary Cancer Guidelines Indicate Selective Internal Radiation Therapy (SIRT) with Y-90 Microspheres as an Option for Post-Chemotherapy Treatment of Intrahepatic Cholangiocarcinoma (iCCA)
SYDNEY, Oct. 11, 2016 /PRNewswire/ -- Sirtex Medical Limited (ASX: SRX) announced today that the European Society of Medical Oncology (ESMO) has indicated the use of SIRT using yttrium-90 (Y-90 ) microspheres as an option in for the treatment of intrahepatic cholangiocarcinoma (iCCA), a form of ...
SIRFLOX Study Published in Journal of Clinical Oncology
SYDNEY, Feb. 23, 2016 /PRNewswire-FirstCall/ -- Sirtex Medical Limited (ASX: SRX) announced that the results of the SIRFLOX study with SIR-SpheresY-90 resin microspheres have been published on-line in the Journal of Clinical Oncology (JCO), the leading peer-reviewed publication of the American So...
SIRFLOX Study Presented at ASCO 2015 Annual Meeting
CHICAGO, June 1, 2015 /PRNewswire/ -- The benefits of adding liver-directed SIR-SpheresY-90 resin microspheres to a current systemic chemotherapy for the first-line treatment of unresectable metastatic colorectal cancer (mCRC) reported in the SIRFLOX study, were presented at the American Soci...
